Why lupus patients discontinue antimalarials in real life: A 50 years-experience from a reference centre.

Olga AraújoJosé Hernández-RodríguezLaura PelegrínMaria FeliuMichael BolandHalbert Hernández-NegrínAlfredo AdánGerard Espinosa Ricard Cervera

Published in: Lupus (2022)

In our 50 years-experience, almost all SLE patients underwent antimalarials. These drugs are usually stopped because of adverse effects, particularly macular toxicity. After a long-term follow-up, patients' compliance to antimalarials was considerably high in our SLE patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
systemic lupus erythematosus
rheumatoid arthritis
disease activity
optical coherence tomography
patient reported